SIMULATIONS PLUS INC (SLP) Stock Price, Quote, News and Summary
NASDAQ:SLP - Nasdaq - US8292141053 - Common Stock
SLP Quote and Key Statistics
SIMULATIONS PLUS INC
NASDAQ:SLP (1/17/2025, 8:27:33 PM)
After market: 29.92 0 (0%)29.92
+0.08 (+0.27%)
SLP Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.04% | ||
| ROA | 4.17% | ||
| ROE | 4.45% | ||
| Debt/Equity | 0 |
SLP Performance and Technical Analysis
SLP Ownership and Analysts
SLP Latest News and Analysis
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
Noteworthy Tuesday Option Activity: TTWO, SLP, WWD
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
Simulations Plus to Participate in the BTIG Digital Health Forum
About SLP
Company Profile
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 243 full-time employees. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. The company operates through two segments: software and services. The company offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.
Company Info
SIMULATIONS PLUS INC
42505 10Th Street West
Lancaster CALIFORNIA 93534 US
CEO: Shawn O'Connor
Employees: 243
Company Website: https://www.simulations-plus.com/
Investor Relations: https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/
Phone: 16617237723
SLP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 34.65 | 35.16B | ||
| DOCS | DOXIMITY INC-CLASS A | 47.96 | 10.03B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.45B | ||
| CERT | CERTARA INC | 29.9 | 1.88B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 14.28 | 1.74B | ||
| PHR | PHREESIA INC | N/A | 1.58B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.57B | ||
| SDGR | SCHRODINGER INC | N/A | 1.38B | ||
| EVH | EVOLENT HEALTH INC - A | 10.99 | 1.17B | ||
| HSTM | HEALTHSTREAM INC | 49.05 | 969.47M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 938.93M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 11.59 | 610.62M |